Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/18/25 17:29 | 9/16/25 | RDNT | Health | Health | Medical Laboratories | Stolper Mark | CA | O | EVP,CFO | 1 | S | -2,586 | 73.89 | 0 | -35 | 68 | D | |||||||||||||||
9/17/25 16:15 | 9/16/25 | RDNT | Health | Health | Medical Laboratories | Katz David Jeffrey | CA | O | EVP,GC | 2 | S | -2,203 | 71.08 | 0 | -31 | 87 | D | |||||||||||||||
9/15/25 07:00 | 9/11/25 | RDNT | Health | Health | Medical Laboratories | Wesdorp Cornelis | CA | O | P,CEO,Di | 3 | S | -173 | 69.01 | 0 | -3 | 54 | D | |||||||||||||||
9/12/25 17:10 | 9/10/25 | RDNT | Health | Health | Medical Laboratories | Hames Norman R | CA | O | P,COO-We | 2 | S | -1,083 | 72.19 | 0 | -15 | 239 | D | |||||||||||||||
8/21/25 16:15 | 8/19/25 | RDNT | Health | Health | Medical Laboratories | Jayanathan Ranjan | CA | O | CIO | 1 | S | -4,428 | 67.50 | 0 | -66 | 138 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |